DCAT Week spearheads ambitious US expansion plan

Tholey, Germany: – Spray dosage system specialist URSATEC GmbH is returning to North America’s premier pharma industry networking event, DCAT Week, for a second successive year to showcase its preservative-free solutions.

URSATEC and its strategic partner Aero Pump aim to host a series of discussions with industry partners, regulatory stakeholders, and pharmaceutical manufacturers during DCAT Week to accelerate their ambitious plans to bring their preservative-free solutions to the American market.

URSATEC and Aero Pump Team

The URSATEC team, headed by General Manager Dr. Andreas Bilstein, will host meetings at Suite 614 at Hotel Fifty Sonesta Select, one of the 8 selected hotels of the conference venue.

Dr. Bilstein will be accompanied by URSATEC Head of Business Development & Sales, Julia Krüger, and Head of Sales for partner innovators Aero Pump GmbH, Rouven Kraus.

Andreas Bilstein will also address the DCAT Conference on Day One (Monday March 17, 1104 –1111 hrs.) as part of the Member Company Announcement Forum. His presentation will outline joint URSATEC and Aero Pump plans to expand their range of preservative-free Drug Delivery Systems for the U.S. Market, building on their successful track record in Europe, where their innovative primary packaging solutions have become standards for safe and effective applications in pharmaceuticals, medical devices, food supplements, and cosmetics.

American plans

The expansion plan for the North American market will be based on partnership with a U.S.-based production facility to ensure a local supply chain, establishing a dedicated local team to navigate FDA approval processes, adapt the nasal spray, ophthalmic, oral, and dermal drug delivery product portfolio to American needs, and collaboration with U.S. pharma partners to integrate preservative-free solutions into their portfolios.

The plan will involve investment of up to $15 million in its initial phase to cover setting up a U.S. aseptic filling site, and product R&D. Long term device manufacturing scale-up could involve investment of more than $100 million, with a timeline extending from first launches this year to full-scale manufacturing of finished dosage forms in the U.S. by 2028.

Dr. Bilstein will show how the recent shift toward preservative-free drug delivery solutions in the USA creates ideal opportunities to adapt URSATEC and Aero Pump innovations.

About URSATEC

Founded in 1993 and based at Tholey in southwest Germany’s Hunsrück region, URSATEC GmbH is an innovative development and sales organization that specializes in spray dosage systems for preservative-free solutions. The company’s mission is to support the global healthcare industry in providing purer products by developing and distributing dosing systems and safe, effective, as well as well-tolerated finished products designed for preservative-free delivery.

URSATEC offers a comprehensive suite of services providing preservative-free solutions to four principal sectors: Pharmaceuticals, Medical Devices, Cosmetics, and Food Supplements. It’s ONE Source® portfolio of services include product development, raw material and procurement, source management, dosage systems tailored for various applications including nasal, oral, dermal, and otological uses, sterilization and aseptic filling processes, laboratory testing and validation, and regulatory support.

All URSATEC white-label offerings are based on its proprietary technologies for preservative-free dose delivery. In addition, URSATEC solutions can be applied to inhalation and breathing aids, food supplement dispensers, cosmetic ointments and gels, lip and eyelid relief, intimate care sprays, and pharmaceutical dosage of drugs such as xylometazoline, oxymetazoline, and corticosteroids.

For further information, see https://www.ursatec.com/en/

About DCAT Week 2025

The Drug, Chemical & Associated Technologies Association (DCAT), founded in 1890, has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.

DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.

Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, is considered as a premier global event for companies engaged in the biotech and pharmaceutical manufacturing value chains.

DCAT Week 2025 will take place over four days from Monday, March 17, 2023, with its central venue at the InterContinental Barclay Hotel in New York City. It is expected to attract more than 10,000 attendees, overwhelmingly C-Suite executives and high-level decision makers, representing some 700 companies drawn from more than 50 nations worldwide.

The week will conclude with the 97th DCAT Annual Dinner, again held in the Grand Ballroom of the New York Hilton on the evening of Thursday, March 20.

The event is organized by DCAT with more information at: https://dcatweek.org

Resources

Click on URSATEC at DCAT Week 2025 for more information.